25 XP   0   0   10

Pulmatrix Inc
Buy, Hold or Sell?

Let's analyse Pulmatrix together

PenkeI guess you are interested in Pulmatrix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pulmatrix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pulmatrix Inc

I send you an email if I find something interesting about Pulmatrix Inc.

Quick analysis of Pulmatrix (30 sec.)










What can you expect buying and holding a share of Pulmatrix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$4.93
Expected worth in 1 year
$1.34
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-3.59
Return On Investment
-176.0%

For what price can you sell your share?

Current Price per Share
$2.04
Expected price per share
$1.55 - $2.34
How sure are you?
50%

1. Valuation of Pulmatrix (5 min.)




Live pricePrice per Share (EOD)

$2.04

Intrinsic Value Per Share

$-46.44 - $-22.54

Total Value Per Share

$-41.52 - $-17.61

2. Growth of Pulmatrix (5 min.)




Is Pulmatrix growing?

Current yearPrevious yearGrowGrow %
How rich?$17.9m$36.8m-$14.7m-66.8%

How much money is Pulmatrix making?

Current yearPrevious yearGrowGrow %
Making money-$3.4m-$4.6m$1.1m32.8%
Net Profit Margin-201.1%-319.1%--

How much money comes from the company's main activities?

3. Financial Health of Pulmatrix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#595 / 1010

Most Revenue
#449 / 1010

Most Profit
#370 / 1010

Most Efficient
#627 / 1010

What can you expect buying and holding a share of Pulmatrix? (5 min.)

Welcome investor! Pulmatrix's management wants to use your money to grow the business. In return you get a share of Pulmatrix.

What can you expect buying and holding a share of Pulmatrix?

First you should know what it really means to hold a share of Pulmatrix. And how you can make/lose money.

Speculation

The Price per Share of Pulmatrix is $2.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pulmatrix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pulmatrix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.93. Based on the TTM, the Book Value Change Per Share is $-0.90 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pulmatrix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.57-28.0%-0.92-45.3%-1.29-63.2%-1.31-64.2%-1.33-65.2%
Usd Book Value Change Per Share-0.52-25.3%-0.90-44.0%-1.12-54.8%0.084.1%0.136.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.52-25.3%-0.90-44.0%-1.12-54.8%0.084.1%0.136.2%
Usd Price Per Share1.86-2.37-4.72-2.05-2.56-
Price to Earnings Ratio-0.82--0.66--0.91--0.49--0.79-
Price-to-Total Gains Ratio-3.60--2.76--4.16--2.20--5.28-
Price to Book Ratio0.38-0.39-0.46-0.31-0.48-
Price-to-Total Gains Ratio-3.60--2.76--4.16--2.20--5.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.04
Number of shares490
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.900.08
Usd Total Gains Per Share-0.900.08
Gains per Quarter (490 shares)-439.8541.28
Gains per Year (490 shares)-1,759.41165.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1759-17690165155
20-3519-35280330320
30-5278-52870495485
40-7038-70460660650
50-8797-88050825815
60-10556-105641990980
70-12316-12323111551145
80-14075-14082113201310
90-15835-15841114851475
100-17594-17600116501640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.044.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%10.034.00.022.7%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.043.02.3%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%10.034.00.022.7%

Fundamentals of Pulmatrix

About Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; and a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of PUR1900. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 16:00:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pulmatrix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pulmatrix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • A Net Profit Margin of -94.6% means that $-0.95 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pulmatrix Inc:

  • The MRQ is -94.6%. The company is making a huge loss. -2
  • The TTM is -201.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-94.6%TTM-201.1%+106.5%
TTM-201.1%YOY-319.1%+118.0%
TTM-201.1%5Y-272.1%+71.0%
5Y-272.1%10Y-1,280.8%+1,008.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-94.6%-207.2%+112.6%
TTM-201.1%-216.8%+15.7%
YOY-319.1%-282.3%-36.8%
5Y-272.1%-436.8%+164.7%
10Y-1,280.8%-597.3%-683.5%
1.1.2. Return on Assets

Shows how efficient Pulmatrix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • -6.1% Return on Assets means that Pulmatrix generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pulmatrix Inc:

  • The MRQ is -6.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.1%TTM-10.1%+4.0%
TTM-10.1%YOY-9.8%-0.4%
TTM-10.1%5Y-12.2%+2.1%
5Y-12.2%10Y-17.2%+5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.1%-13.3%+7.2%
TTM-10.1%-12.8%+2.7%
YOY-9.8%-11.6%+1.8%
5Y-12.2%-13.8%+1.6%
10Y-17.2%-15.6%-1.6%
1.1.3. Return on Equity

Shows how efficient Pulmatrix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • -11.6% Return on Equity means Pulmatrix generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pulmatrix Inc:

  • The MRQ is -11.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.6%TTM-15.7%+4.1%
TTM-15.7%YOY-12.7%-3.0%
TTM-15.7%5Y-22.1%+6.4%
5Y-22.1%10Y-27.1%+5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.6%-16.9%+5.3%
TTM-15.7%-16.1%+0.4%
YOY-12.7%-14.9%+2.2%
5Y-22.1%-19.3%-2.8%
10Y-27.1%-20.1%-7.0%

1.2. Operating Efficiency of Pulmatrix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pulmatrix is operating .

  • Measures how much profit Pulmatrix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • An Operating Margin of -101.0% means the company generated $-1.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pulmatrix Inc:

  • The MRQ is -101.0%. The company is operating very inefficient. -2
  • The TTM is -218.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-101.0%TTM-218.1%+117.0%
TTM-218.1%YOY-324.0%+105.9%
TTM-218.1%5Y-214.7%-3.4%
5Y-214.7%10Y-1,020.4%+805.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.0%-298.0%+197.0%
TTM-218.1%-238.5%+20.4%
YOY-324.0%-288.4%-35.6%
5Y-214.7%-486.2%+271.5%
10Y-1,020.4%-628.4%-392.0%
1.2.2. Operating Ratio

Measures how efficient Pulmatrix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.01 means that the operating costs are $2.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pulmatrix Inc:

  • The MRQ is 2.010. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.307. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.010TTM3.307-1.297
TTM3.307YOY5.163-1.856
TTM3.3075Y3.482-0.174
5Y3.48210Y18.696-15.215
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0103.235-1.225
TTM3.3073.310-0.003
YOY5.1633.838+1.325
5Y3.4825.679-2.197
10Y18.6967.823+10.873

1.3. Liquidity of Pulmatrix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pulmatrix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.33 means the company has $5.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pulmatrix Inc:

  • The MRQ is 5.332. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.280. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.332TTM6.280-0.948
TTM6.280YOY8.007-1.727
TTM6.2805Y5.832+0.448
5Y5.83210Y6.894-1.062
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3323.863+1.469
TTM6.2804.169+2.111
YOY8.0075.337+2.670
5Y5.8326.122-0.290
10Y6.8946.434+0.460
1.3.2. Quick Ratio

Measures if Pulmatrix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • A Quick Ratio of 5.14 means the company can pay off $5.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pulmatrix Inc:

  • The MRQ is 5.142. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.023. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.142TTM6.023-0.881
TTM6.023YOY7.671-1.648
TTM6.0235Y5.647+0.376
5Y5.64710Y6.682-1.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1423.504+1.638
TTM6.0233.991+2.032
YOY7.6715.371+2.300
5Y5.6476.088-0.441
10Y6.6826.395+0.287

1.4. Solvency of Pulmatrix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pulmatrix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pulmatrix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that Pulmatrix assets are financed with 47.0% credit (debt) and the remaining percentage (100% - 47.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pulmatrix Inc:

  • The MRQ is 0.470. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.358. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.470TTM0.358+0.112
TTM0.358YOY0.230+0.128
TTM0.3585Y0.369-0.010
5Y0.36910Y0.303+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4700.339+0.131
TTM0.3580.337+0.021
YOY0.2300.271-0.041
5Y0.3690.368+0.001
10Y0.3030.388-0.085
1.4.2. Debt to Equity Ratio

Measures if Pulmatrix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pulmatrix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 88.7% means that company has $0.89 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pulmatrix Inc:

  • The MRQ is 0.887. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.603. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.887TTM0.603+0.284
TTM0.603YOY0.299+0.303
TTM0.6035Y0.796-0.194
5Y0.79610Y0.575+0.222
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8870.392+0.495
TTM0.6030.403+0.200
YOY0.2990.335-0.036
5Y0.7960.427+0.369
10Y0.5750.461+0.114

2. Market Valuation of Pulmatrix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pulmatrix generates.

  • Above 15 is considered overpriced but always compare Pulmatrix to the Biotechnology industry mean.
  • A PE ratio of -0.82 means the investor is paying $-0.82 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pulmatrix Inc:

  • The EOD is -0.894. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.815. Based on the earnings, the company is expensive. -2
  • The TTM is -0.662. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.894MRQ-0.815-0.079
MRQ-0.815TTM-0.662-0.154
TTM-0.662YOY-0.913+0.251
TTM-0.6625Y-0.487-0.175
5Y-0.48710Y-0.788+0.301
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.894-2.300+1.406
MRQ-0.815-2.656+1.841
TTM-0.662-2.718+2.056
YOY-0.913-4.145+3.232
5Y-0.487-6.258+5.771
10Y-0.788-6.315+5.527
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pulmatrix Inc:

  • The EOD is -0.804. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.733. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.546. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.804MRQ-0.733-0.071
MRQ-0.733TTM-0.546-0.187
TTM-0.546YOY-0.881+0.335
TTM-0.5465Y-0.330-0.216
5Y-0.33010Y-0.780+0.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.804-2.974+2.170
MRQ-0.733-3.306+2.573
TTM-0.546-3.508+2.962
YOY-0.881-5.613+4.732
5Y-0.330-8.378+8.048
10Y-0.780-8.873+8.093
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pulmatrix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.38 means the investor is paying $0.38 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pulmatrix Inc:

  • The EOD is 0.414. Based on the equity, the company is cheap. +2
  • The MRQ is 0.378. Based on the equity, the company is cheap. +2
  • The TTM is 0.391. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.414MRQ0.378+0.037
MRQ0.378TTM0.391-0.013
TTM0.391YOY0.462-0.071
TTM0.3915Y0.308+0.083
5Y0.30810Y0.484-0.176
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4141.914-1.500
MRQ0.3782.116-1.738
TTM0.3912.097-1.706
YOY0.4622.881-2.419
5Y0.3083.550-3.242
10Y0.4843.936-3.452
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pulmatrix Inc.

3.1. Institutions holding Pulmatrix Inc

Institutions are holding 8.594% of the shares of Pulmatrix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp3.21230.000311732160565.4429
2023-12-31BlackRock Inc1.503205490000
2023-12-31Sabby Management LLC1.48370.100854188-97162-64.1969
2023-12-31Vanguard Group Inc0.96050350821354862.9145
2023-12-31Geode Capital Management, LLC0.675202466000
2023-12-31State Street Corporation0.381801394500
2023-12-31Tower Research Capital LLC0.09770.000135702597.8224
2023-12-31Advisor Group Holdings, Inc.0.007602765022.1239
2023-12-31UBS Group AG0.00450165-1057-86.4975
2023-12-31Wells Fargo & Co0.000802813.7037
2023-12-31Morgan Stanley - Brokerage Accounts0.000702500
2023-12-31Hanson Mcclain Inc0.00010300
2023-09-30HRT FINANCIAL LLC000-12113-100
Total 8.32810.1012304163-90418-29.7%

3.2. Funds holding Pulmatrix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.96050.00013508200
2024-02-29Fidelity Extended Market Index0.37540.000113710-66-0.4791
2023-12-31Bridgeway Ultra-Small Company0.26560.0208970000
2024-02-29Fidelity Total Market Index0.12190445300
2024-02-29Fidelity Series Total Market Index0.11380415500
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07780.0001284300
2023-12-31Northern Trust Extended Eq Market Idx0.06390.0001233300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06390.0001233300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06250.0001228340.1755
2024-02-29Fidelity Nasdaq Composite Index0.06080222000
2023-12-31NT US Market Cap Idx Fd - L0.0041015100
2023-12-31Northern Trust Wilshire 50000.0041015100
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00250.00019200
2024-02-29Spartan Extended Market Index Pool E0.002408666330
2023-12-31SSgA U.S. Extended Market Index Class I0.001806700
2024-03-31State St US Extended Mkt Indx NL Cl C0.001806700
2024-02-29Fidelity U.S. Equity Index Ins Trust0.001036360
2023-12-31SSgA U.S. Total Market Index Strategy0.000501900
Total 2.18430.021579781+40+0.1%

3.3. Insider Transactions

Insiders are holding 0.001% of the shares of Pulmatrix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2015-06-16David MakiBUY727506.88
2015-06-16Steven GillisBUY727506.88
2015-06-15Terrance McguireBUY1066936.88
2015-06-15Terrance McguireBUY1066936.88
2015-03-23Innovative Sciences In OculusSELL3500002.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pulmatrix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.516-0.898+74%-1.118+117%0.084-713%0.126-510%
Book Value Per Share--4.9276.047-19%10.086-51%7.660-36%6.216-21%
Current Ratio--5.3326.280-15%8.007-33%5.832-9%6.894-23%
Debt To Asset Ratio--0.4700.358+31%0.230+104%0.369+28%0.303+55%
Debt To Equity Ratio--0.8870.603+47%0.299+196%0.796+11%0.575+54%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.570-0.923+62%-1.289+126%-1.309+129%-1.329+133%
Free Cash Flow Per Share---0.634-1.140+80%-1.331+110%-0.897+42%-0.892+41%
Free Cash Flow To Equity Per Share---0.63423.846-103%-1.162+83%4.972-113%2.652-124%
Gross Profit Margin--1.0821.020+6%1.000+8%1.004+8%1.0840%
Intrinsic Value_10Y_max---22.541--------
Intrinsic Value_10Y_min---46.443--------
Intrinsic Value_1Y_max---3.382--------
Intrinsic Value_1Y_min---5.063--------
Intrinsic Value_3Y_max---9.305--------
Intrinsic Value_3Y_min---14.947--------
Intrinsic Value_5Y_max---14.196--------
Intrinsic Value_5Y_min---24.467--------
Market Cap7450651.200+9%6793250.1008665042.513-22%17229630.900-61%7477570.146-9%9340387.347-27%
Net Profit Margin---0.946-2.011+113%-3.191+237%-2.721+188%-12.808+1254%
Operating Margin---1.010-2.181+116%-3.240+221%-2.147+112%-10.204+910%
Operating Ratio--2.0103.307-39%5.163-61%3.482-42%18.696-89%
Pb Ratio0.414+9%0.3780.391-3%0.462-18%0.308+23%0.484-22%
Pe Ratio-0.894-10%-0.815-0.662-19%-0.913+12%-0.487-40%-0.788-3%
Price Per Share2.040+9%1.8602.373-22%4.718-61%2.047-9%2.557-27%
Price To Free Cash Flow Ratio-0.804-10%-0.733-0.546-26%-0.881+20%-0.330-55%-0.780+6%
Price To Total Gains Ratio-3.951-10%-3.602-2.758-23%-4.160+16%-2.198-39%-5.282+47%
Quick Ratio--5.1426.023-15%7.671-33%5.647-9%6.682-23%
Return On Assets---0.061-0.101+65%-0.098+59%-0.122+99%-0.172+181%
Return On Equity---0.116-0.157+36%-0.127+10%-0.221+91%-0.271+134%
Total Gains Per Share---0.516-0.898+74%-1.118+117%0.084-713%0.126-510%
Usd Book Value--17995000.00022083750.000-19%36837750.000-51%27978000.000-36%22702900.000-21%
Usd Book Value Change Per Share---0.516-0.898+74%-1.118+117%0.084-713%0.126-510%
Usd Book Value Per Share--4.9276.047-19%10.086-51%7.660-36%6.216-21%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.570-0.923+62%-1.289+126%-1.309+129%-1.329+133%
Usd Free Cash Flow---2316000.000-4165250.000+80%-4860500.000+110%-3277550.000+42%-3256200.000+41%
Usd Free Cash Flow Per Share---0.634-1.140+80%-1.331+110%-0.897+42%-0.892+41%
Usd Free Cash Flow To Equity Per Share---0.63423.846-103%-1.162+83%4.972-113%2.652-124%
Usd Market Cap7450651.200+9%6793250.1008665042.513-22%17229630.900-61%7477570.146-9%9340387.347-27%
Usd Price Per Share2.040+9%1.8602.373-22%4.718-61%2.047-9%2.557-27%
Usd Profit---2083000.000-3496000.000+68%-4644250.000+123%-4631800.000+122%-4778575.000+129%
Usd Revenue--2202000.0001824500.000+21%1517750.000+45%1954100.000+13%1050700.000+110%
Usd Total Gains Per Share---0.516-0.898+74%-1.118+117%0.084-713%0.126-510%
 EOD+5 -3MRQTTM+21 -13YOY+22 -125Y+16 -2010Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Pulmatrix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.894
Price to Book Ratio (EOD)Between0-10.414
Net Profit Margin (MRQ)Greater than0-0.946
Operating Margin (MRQ)Greater than0-1.010
Quick Ratio (MRQ)Greater than15.142
Current Ratio (MRQ)Greater than15.332
Debt to Asset Ratio (MRQ)Less than10.470
Debt to Equity Ratio (MRQ)Less than10.887
Return on Equity (MRQ)Greater than0.15-0.116
Return on Assets (MRQ)Greater than0.05-0.061
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Pulmatrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.070
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets33,958
Total Liabilities15,963
Total Stockholder Equity17,995
 As reported
Total Liabilities 15,963
Total Stockholder Equity+ 17,995
Total Assets = 33,958

Assets

Total Assets33,958
Total Current Assets20,843
Long-term Assets13,115
Total Current Assets
Cash And Cash Equivalents 19,173
Net Receivables 928
Other Current Assets 742
Total Current Assets  (as reported)20,843
Total Current Assets  (calculated)20,843
+/-0
Long-term Assets
Property Plant Equipment 11,467
Long-term Assets Other 176
Long-term Assets  (as reported)13,115
Long-term Assets  (calculated)11,643
+/- 1,472

Liabilities & Shareholders' Equity

Total Current Liabilities3,909
Long-term Liabilities12,054
Total Stockholder Equity17,995
Total Current Liabilities
Short-term Debt 429
Accounts payable 1,915
Other Current Liabilities 947
Total Current Liabilities  (as reported)3,909
Total Current Liabilities  (calculated)3,291
+/- 618
Long-term Liabilities
Capital Lease Obligations 8,756
Long-term Liabilities  (as reported)12,054
Long-term Liabilities  (calculated)8,756
+/- 3,298
Total Stockholder Equity
Retained Earnings -287,597
Other Stockholders Equity 305,592
Total Stockholder Equity (as reported)17,995
Total Stockholder Equity (calculated)17,995
+/-0
Other
Cash and Short Term Investments 19,173
Common Stock Shares Outstanding 3,652
Current Deferred Revenue618
Liabilities and Stockholders Equity 33,958
Net Debt -10,417
Net Invested Capital 17,995
Net Working Capital 16,934
Property Plant and Equipment Gross 13,203
Short Long Term Debt Total 8,756



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-30
> Total Assets 
0
0
0
148
712
1,123
1,425
15,576
14,647
13,274
11,874
10,680
50,313
47,664
44,873
40,223
28,819
25,480
16,663
22,794
23,520
19,325
15,978
13,724
20,576
16,285
14,723
13,991
37,047
32,925
36,098
30,822
35,072
42,956
38,169
69,850
65,433
55,748
58,817
54,303
49,398
46,450
40,953
36,059
31,393
36,770
33,958
33,95836,77031,39336,05940,95346,45049,39854,30358,81755,74865,43369,85038,16942,95635,07230,82236,09832,92537,04713,99114,72316,28520,57613,72415,97819,32523,52022,79416,66325,48028,81940,22344,87347,66450,31310,68011,87413,27414,64715,5761,4251,123712148000
   > Total Current Assets 
0
0
0
100
156
296
262
15,574
14,644
13,169
11,769
10,523
26,017
23,359
20,462
15,764
11,798
8,335
4,759
10,954
11,730
7,550
4,246
2,052
8,960
4,720
3,280
3,382
32,931
28,839
31,417
26,247
29,056
37,119
32,538
64,494
60,469
54,438
54,778
50,608
45,845
43,225
38,147
32,800
27,381
23,229
20,843
20,84323,22927,38132,80038,14743,22545,84550,60854,77854,43860,46964,49432,53837,11929,05626,24731,41728,83932,9313,3823,2804,7208,9602,0524,2467,55011,73010,9544,7598,33511,79815,76420,46223,35926,01710,52311,76913,16914,64415,574262296156100000
       Cash And Cash Equivalents 
0
0
0
96
53
89
10
15,571
14,317
12,880
11,570
10,357
25,507
22,026
18,902
14,753
10,788
7,313
4,182
10,541
10,976
6,360
3,550
1,553
8,341
3,806
2,563
2,146
31,817
27,879
23,440
24,402
27,255
34,508
31,657
63,445
56,903
53,491
53,840
47,534
42,905
40,683
35,628
30,753
25,791
21,336
19,173
19,17321,33625,79130,75335,62840,68342,90547,53453,84053,49156,90363,44531,65734,50827,25524,40223,44027,87931,8172,1462,5633,8068,3411,5533,5506,36010,97610,5414,1827,31310,78814,75318,90222,02625,50710,35711,57012,88014,31715,57110895396000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
481
257
260
0
206
206
0
305
1
153
1
0
0
0
0
0
7,200
7,200
353
1,217
84
87
1,766
9
67
1,113
645
476
1,298
740
418
841
928
9288414187401,2984766451,1136791,76687841,2173537,2007,20000000115313050206206026025748100000000000000
       Other Current Assets 
0
0
0
4
103
207
252
3
327
289
50
114
510
1,333
1,079
206
206
206
371
114
754
885
695
346
618
914
27
1,236
211
158
221
130
209
183
130
269
150
283
316
244
135
106
166
294
272
405
742
7424052722941661061352443162831502691301832091302211582111,236279146183466958857541143712062062061,0791,3335101145028932732522071034000
   > Long-term Assets 
0
0
0
48
556
827
1,163
2
3
105
105
157
24,296
24,305
24,411
24,459
17,021
17,145
11,904
11,840
11,790
11,775
11,732
11,672
11,616
11,565
11,443
10,609
4,116
4,086
4,681
4,575
6,016
5,837
5,631
5,356
4,964
1,310
4,039
3,695
3,553
3,225
2,806
3,259
4,012
13,541
13,115
13,11513,5414,0123,2592,8063,2253,5533,6954,0391,3104,9645,3565,6315,8376,0164,5754,6814,0864,11610,60911,44311,56511,61611,67211,73211,77511,79011,84011,90417,14517,02124,45924,41124,30524,296157105105321,16382755648000
       Property Plant Equipment 
0
0
0
4
3
3
3
2
3
105
105
157
545
558
685
783
875
999
786
722
672
657
614
554
498
447
394
354
335
305
900
794
2,235
2,056
1,850
1,575
1,387
1,106
2,414
2,070
1,713
1,325
945
888
556
11,852
11,467
11,46711,8525568889451,3251,7132,0702,4141,1061,3871,5751,8502,0562,235794900305335354394447498554614657672722786999875783685558545157105105323334000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
15,942
15,942
15,942
15,942
15,942
15,942
10,914
10,914
10,914
10,914
10,914
10,914
10,914
10,914
10,845
10,051
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
0
0
0
368
0
0
0
0
0
0
0000003680003,5773,5773,5773,5773,5773,5773,5773,5773,57710,05110,84510,91410,91410,91410,91410,91410,91410,91410,91415,94215,94215,94215,94215,94215,942000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
7,534
7,534
7,534
7,534
15,942
15,942
10,914
10,914
10,914
10,914
10,914
10,914
10,914
10,914
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000010,91410,91410,91410,91410,91410,91410,91410,91415,94215,9427,5347,5347,5347,534000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
23,751
23,747
23,726
23,676
16,146
16,146
11,118
11,118
11,118
11,118
11,118
204
204
204
204
204
204
204
204
204
204
204
2
204
0
204
1,625
1,625
1,840
1,900
1,861
0
3,456
0
0
003,45601,8611,9001,8401,6251,6252040204220420420420420420420420420420420411,11811,11811,11811,11811,11816,14616,14623,67623,72623,74723,751000000000000
> Total Liabilities 
0
0
0
101
900
1,328
1,816
947
550
575
575
635
11,003
11,758
12,267
12,053
8,668
8,009
7,902
6,892
7,731
6,545
5,841
6,196
3,778
3,651
2,879
3,795
18,955
18,199
25,079
23,886
21,187
19,456
15,030
13,204
12,340
10,555
11,368
11,546
10,959
11,404
9,844
9,049
7,944
16,889
15,963
15,96316,8897,9449,0499,84411,40410,95911,54611,36810,55512,34013,20415,03019,45621,18723,88625,07918,19918,9553,7952,8793,6513,7786,1965,8416,5457,7316,8927,9028,0098,66812,05312,26711,75811,0036355755755509471,8161,328900101000
   > Total Current Liabilities 
0
0
0
101
900
1,328
1,816
947
550
575
575
635
1,327
2,475
3,605
4,014
4,109
4,105
4,650
4,335
5,892
6,510
5,840
6,196
3,778
3,651
2,879
3,795
12,753
11,728
17,200
17,359
14,636
10,566
8,254
7,088
6,917
5,132
4,442
5,377
5,601
6,324
5,022
4,732
3,597
4,429
3,909
3,9094,4293,5974,7325,0226,3245,6015,3774,4425,1326,9177,0888,25410,56614,63617,35917,20011,72812,7533,7952,8793,6513,7786,1965,8406,5105,8924,3354,6504,1054,1094,0143,6052,4751,3276355755755509471,8161,328900101000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
2
0
0
0
413
1,029
1,682
2,233
2,511
2,586
2,661
2,745
3,896
3,221
2,524
0
0
0
0
894
1,210
675
511
861
997
1,135
1,159
1,184
898
1,431
1,566
1,702
1,281
857
779
358
199
429
4291993587798571,2811,7021,5661,4318981,1841,1591,1359978615116751,21089400002,5243,2213,8962,7452,6612,5862,5112,2331,6821,0294130002000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,029
0
0
0
2,586
2,661
4,549
3,896
3,221
2,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,5243,2213,8964,5492,6612,5860001,02900000000000000
       Accounts payable 
0
0
0
61
308
338
833
0
550
575
575
635
314
927
1,090
1,272
664
401
747
235
564
1,027
457
1,192
1,507
1,367
1,183
1,611
543
1,159
600
1,274
291
630
925
918
1,508
875
839
1,227
728
1,155
1,188
578
929
707
1,915
1,9157079295781,1881,1557281,2278398751,5089189256302911,2746001,1595431,6111,1831,3671,5071,1924571,0275642357474016641,2721,090927314635575575550083333830861000
       Other Current Liabilities 
0
0
0
40
592
990
983
947
550
573
575
635
1,013
1,135
1,486
1,060
1,212
1,193
1,317
1,439
2,583
1,587
2,162
2,480
2,271
2,284
1,696
2,184
1,231
1,265
2,514
3,548
3,445
4,681
2,028
1,868
1,191
1,385
1,233
1,067
1,610
2,748
1,638
1,662
1,201
2,535
947
9472,5351,2011,6621,6382,7481,6101,0671,2331,3851,1911,8682,0284,6813,4453,5482,5141,2651,2312,1841,6962,2842,2712,4802,1621,5872,5831,4391,3171,1931,2121,0601,4861,1351,01363557557355094798399059240000
   > Long-term Liabilities 
0
0
0
61
308
338
833
0
0
2
0
0
9,676
9,283
8,662
8,039
4,559
3,904
3,252
2,557
1,839
35
1
3,716
1,507
1,367
1,183
1,611
6,202
6,471
7,879
6,527
6,551
8,890
6,776
6,116
5,423
5,423
6,926
6,169
5,358
5,080
4,822
4,317
4,347
12,460
12,054
12,05412,4604,3474,3174,8225,0805,3586,1696,9265,4235,4236,1166,7768,8906,5516,5277,8796,4716,2021,6111,1831,3671,5073,7161351,8392,5573,2523,9044,5598,0398,6629,2839,6760020083333830861000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
6,706
6,313
5,692
5,069
4,548
3,893
3,217
2,522
1,804
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000001,8042,5223,2173,8934,5485,0695,6926,3136,706000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
11
11
35
35
35
35
1
0
0
0
0
0
6,202
6,471
7,879
6,527
5,367
7,992
6,168
5,810
5,423
5,423
6,069
5,739
5,358
5,080
4,822
0
4,347
0
0
004,34704,8225,0805,3585,7396,0695,4235,4235,8106,1687,9925,3676,5277,8796,4716,20200000135353535111111111111000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
2,970
2,970
2,970
2,970
11
11
35
35
35
35
1
0
0
0
0
0
6,202
6,471
0
0
0
0
0
0
5,423
0
0
0
0
0
0
0
0
0
0
00000000005,4230000006,4716,2020000013535353511112,9702,9702,9702,970000000000000
> Total Stockholder Equity
0
0
0
47
-188
-205
-391
14,629
14,097
12,699
11,299
10,045
39,310
35,906
32,606
28,170
20,151
17,471
8,761
15,902
15,789
12,780
10,137
7,528
16,798
12,634
11,844
10,196
18,092
14,726
11,019
6,936
13,885
23,500
23,139
56,646
53,093
45,193
47,449
42,757
38,439
35,046
31,109
27,010
23,449
19,881
17,995
17,99519,88123,44927,01031,10935,04638,43942,75747,44945,19353,09356,64623,13923,50013,8856,93611,01914,72618,09210,19611,84412,63416,7987,52810,13712,78015,78915,9028,76117,47120,15128,17032,60635,90639,31010,04511,29912,69914,09714,629-391-205-18847000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
2
2
2
2
2
5
5
0
1
2
2
2
2
3
3
4
6
6
6
0
0
0
0
0
0
0
0
0
00000000066643322221055222221111111000000000000
   Retained Earnings Total Equity0000000000-242,425-238,573-234,469-231,570-221,017-219,847-215,161-211,120-207,565-199,721-194,565-190,227-185,411-179,223-174,002-169,478-165,026-159,429-155,946-146,116-142,960-133,772-128,103-123,567-118,635-10,360-8,806-7,094-5,38400000000
   Accumulated Other Comprehensive Income 000000000000000-2,285-2,285-2,247-2,204-2,166-2,11600-2,870-2,87000-2,671-2,67100-2,605-2,605-47,664-50,313-300-2-2-1-1-10000
   Capital Surplus 
0
0
0
0
0
0
0
0
19,481
19,793
20,105
20,405
157,944
159,472
160,708
161,941
163,110
163,586
164,706
175,329
180,813
182,256
184,137
186,749
202,204
202,856
206,409
209,916
225,655
225,844
226,178
226,781
234,899
255,067
257,604
295,213
295,512
0
0
0
0
0
0
0
0
0
0
0000000000295,512295,213257,604255,067234,899226,781226,178225,844225,655209,916206,409202,856202,204186,749184,137182,256180,813175,329164,706163,586163,110161,941160,708159,472157,94420,40520,10519,79319,48100000000
   Treasury Stock00000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
598
840
1,817
2,289
18,298
19,481
19,793
20,105
20,405
157,944
159,472
160,708
161,941
163,110
163,586
164,706
175,329
180,813
182,256
184,137
186,749
202,204
202,856
206,409
209,916
225,655
225,844
226,178
226,781
234,899
255,067
257,604
295,213
295,512
295,796
301,008
301,830
302,647
304,306
304,585
304,934
305,189
305,395
305,592
305,592305,395305,189304,934304,585304,306302,647301,830301,008295,796295,512295,213257,604255,067234,899226,781226,178225,844225,655209,916206,409202,856202,204186,749184,137182,256180,813175,329164,706163,586163,110161,941160,708159,472157,94420,40520,10519,79319,48118,2982,2891,817840598000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,298
Cost of Revenue-1,475
Gross Profit5,8235,823
 
Operating Income (+$)
Gross Profit5,823
Operating Expense-20,563
Operating Income-14,740-14,740
 
Operating Expense (+$)
Research Development15,384
Selling General Administrative6,520
Selling And Marketing Expenses1,341
Operating Expense20,56323,245
 
Net Interest Income (+$)
Interest Income866
Interest Expense-0
Other Finance Cost-0
Net Interest Income866
 
Pretax Income (+$)
Operating Income-14,740
Net Interest Income866
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14,121-15,359
EBIT - interestExpense = -14,740
-14,121
-14,121
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-14,740-14,121
Earnings Before Interest and Taxes (EBITDA)-13,265
 
After tax Income (+$)
Income Before Tax-14,121
Tax Provision-0
Net Income From Continuing Ops-16,254-14,121
Net Income-14,121
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses22,038
Total Other Income/Expenses Net619-866
 

Technical Analysis of Pulmatrix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pulmatrix. The general trend of Pulmatrix is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pulmatrix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pulmatrix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.19 < 2.19 < 2.34.

The bearish price targets are: 1.91 > 1.5601 > 1.55.

Tweet this
Pulmatrix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pulmatrix Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pulmatrix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pulmatrix Inc.

Pulmatrix Inc Daily Moving Average Convergence/Divergence (MACD) ChartPulmatrix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pulmatrix Inc. The current adx is .

Pulmatrix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pulmatrix Inc.

Pulmatrix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pulmatrix Inc.

Pulmatrix Inc Daily Relative Strength Index (RSI) ChartPulmatrix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pulmatrix Inc.

Pulmatrix Inc Daily Stochastic Oscillator ChartPulmatrix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pulmatrix Inc.

Pulmatrix Inc Daily Commodity Channel Index (CCI) ChartPulmatrix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pulmatrix Inc.

Pulmatrix Inc Daily Chande Momentum Oscillator (CMO) ChartPulmatrix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pulmatrix Inc.

Pulmatrix Inc Daily Williams %R ChartPulmatrix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pulmatrix Inc.

Pulmatrix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pulmatrix Inc.

Pulmatrix Inc Daily Average True Range (ATR) ChartPulmatrix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pulmatrix Inc.

Pulmatrix Inc Daily On-Balance Volume (OBV) ChartPulmatrix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pulmatrix Inc.

Pulmatrix Inc Daily Money Flow Index (MFI) ChartPulmatrix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pulmatrix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Pulmatrix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pulmatrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.070
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pulmatrix with someone you think should read this too:
  • Are you bullish or bearish on Pulmatrix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pulmatrix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pulmatrix Inc

I send you an email if I find something interesting about Pulmatrix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pulmatrix Inc.

Receive notifications about Pulmatrix Inc in your mailbox!